Profile data is unavailable for this security.
About the company
Universe Pharmaceuticals Inc is a China-based holding company mainly engaged in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives (TCMD) products targeting the elderly. Through its subsidiary, the Company sells TCMD products, biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces (TCMPs), and dietary supplements manufactured by third-party pharmaceutical companies. Its TCMD products fall into two categories: chronic condition treatments as well as cold and flu medications, including Guben Yanling Pill, Shenrong Weisheng Pill, Fengshitong Medicinal Liquor, Isatis Root Granule and Qiangli Pipa Syrup. Its major customers are pharmaceutical companies, hospitals, clinics and drugstore chains. The Company mainly conducts its businesses within the Chinese market.
- Revenue in USD (TTM)26.73m
- Net income in USD-18.55m
- Incorporated2019
- Employees225.00
- LocationUniverse Pharmaceuticals Inc265 Jingjiu AvenueJinggangshan Econ. And Tech. Dev. ZoneJI'AN 343100ChinaCHN
- Phone+86 7 968403309
- Websitehttp://www.universe-pharmacy.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| cbdMD Inc | 20.64m | -23.42m | 1.73m | 52.00 | -- | 0.5725 | -- | 0.084 | -18.95 | -18.95 | 7.85 | 0.8055 | 0.8817 | 2.01 | 20.35 | 396,856.90 | -82.98 | -38.59 | -112.36 | -41.50 | 63.43 | 63.80 | -94.12 | -87.98 | 0.5172 | -3.89 | 0.3128 | -- | -31.77 | 120.91 | 63.64 | -- | -4.95 | -- |
| SOHM Inc | -100.00bn | -100.00bn | 1.82m | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| InVitro International | 716.89k | 6.22k | 1.82m | 16.00 | 228.57 | 2.49 | -- | 2.54 | 0.0004 | 0.0004 | 0.0402 | 0.0321 | 1.15 | -- | -- | -- | 0.995 | 7.89 | 1.09 | 8.83 | -- | -- | 0.8676 | 5.90 | -- | -- | -- | -- | -5.11 | 1.33 | -87.77 | -16.14 | -- | -- |
| PainReform Ltd | 0.00 | -17.67m | 1.89m | 6.00 | -- | -- | -- | -- | -167.66 | -167.66 | 0.00 | -14.12 | 0.00 | -- | -- | 0.00 | -309.43 | -55.47 | -650.22 | -68.20 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -6.28 | -- | -- | -- |
| Panacea Life Sciences Holdings Inc | 2.76m | -7.67m | 2.08m | 40.00 | -- | -- | -- | 0.7511 | -0.4554 | -0.4554 | 0.164 | -0.5255 | 0.1537 | 1.62 | 10.13 | 69,098.25 | -42.65 | -69.04 | -- | -225.03 | -139.49 | -181.62 | -277.51 | -505.41 | 0.0285 | -2.12 | 4.79 | -- | 46.59 | -- | 12.33 | -- | -- | -- |
| CYANOTECH CORP | 23.30m | -5.45m | 2.65m | 77.00 | -- | 0.2727 | -- | 0.1137 | -0.7939 | -0.7939 | 3.40 | 1.36 | 0.896 | 2.15 | 15.42 | 302,532.50 | -20.98 | -3.46 | -32.30 | -4.46 | 22.66 | 34.54 | -23.41 | -3.58 | 0.307 | -7.00 | 0.42 | -- | -0.4616 | -5.24 | -53.11 | -- | -6.42 | -- |
| Universe Pharmaceuticals Inc | 26.73m | -18.55m | 2.82m | 225.00 | -- | 0.0163 | -- | 0.1056 | -76.44 | -76.44 | 110.26 | 110.02 | 0.4462 | 6.13 | 1.68 | 118,781.90 | -30.97 | 5.31 | -48.85 | 7.07 | 28.27 | 46.26 | -69.40 | 6.25 | 1.46 | -0.6939 | 0.1958 | 0.00 | -19.52 | 2.53 | 29.46 | -- | -21.17 | -- |
| Scorpius Holdings Inc | 10.04m | -29.66m | 2.86m | 82.00 | -- | 0.0813 | -- | 0.2846 | -107.62 | -101.17 | 5.25 | 8.12 | 0.1725 | -- | 16.55 | 122,491.30 | -53.23 | -39.37 | -69.92 | -43.18 | 61.92 | -- | -308.58 | -1,068.21 | 0.6007 | -27.31 | 0.3146 | -- | 1,789.58 | 3.84 | 1.96 | -- | 27.32 | -- |
| Processa Pharmaceuticals Inc | 0.00 | -11.53m | 2.87m | 13.00 | -- | 0.7727 | -- | -- | -4.86 | -4.86 | 0.00 | 1.14 | 0.00 | -- | -- | 0.00 | -176.99 | -84.35 | -209.96 | -90.03 | -- | -- | -- | -- | -- | -- | 0.0022 | -- | -- | -- | 59.45 | -- | -34.05 | -- |
| Psyence Biomedical Ltd | 0.00 | 1.52m | 2.98m | -- | -- | -- | 1.97 | -- | -0.0442 | -0.0442 | 0.00 | -0.3979 | 0.00 | -- | -- | -- | 1.13 | -- | 1.20 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -2.63 | -- | -- | -- |
| Scisparc Ltd | 0.00 | -6.96m | 2.99m | 3.00 | -- | 8.40 | -- | -- | -1.22 | -1.51 | 0.00 | 0.0344 | 0.00 | -- | -- | 0.00 | -92.51 | -69.39 | -152.41 | -111.07 | -- | -- | -- | -527.17 | -- | -- | 0.9371 | -- | 113.73 | -- | -97.61 | -- | -- | -- |
| China Pharma Holdings Inc | 5.54m | -4.74m | 3.42m | 231.00 | -- | 0.5444 | -- | 0.616 | -0.3958 | -0.3958 | 0.4119 | 0.3655 | 0.3848 | 2.38 | 15.81 | 24,002.68 | -32.92 | -29.66 | -55.81 | -55.25 | -34.34 | 6.47 | -85.56 | -73.09 | 0.2605 | -27.44 | 0.377 | -- | -13.48 | -10.68 | 22.50 | -- | -25.78 | -- |
| NovaBay Pharmaceuticals Inc | 11.20m | -16.44m | 3.52m | 24.00 | -- | 3.30 | -- | 0.314 | -53.22 | -53.40 | 7.77 | 0.2195 | 1.34 | 2.22 | 13.83 | 466,625.00 | -119.49 | -61.51 | -196.48 | -83.89 | 60.67 | 59.99 | -89.25 | -86.47 | 0.9103 | -- | 0.0454 | -- | 2.24 | 3.32 | -2.66 | -- | -15.46 | -- |
| Titan Pharmaceuticals Inc | 4.00k | -5.46m | 3.59m | 4.00 | -- | 0.8998 | -- | 898.23 | -6.59 | -6.59 | 0.0049 | 4.37 | 0.0016 | -- | 0.1702 | 1,000.00 | -211.58 | -96.80 | -368.99 | -156.65 | -- | -- | -136,525.00 | -406.26 | -- | -309.96 | 0.00 | -- | -66.97 | -51.16 | 45.43 | -- | -65.61 | -- |
| Sonoma Pharmaceuticals Inc | 13.55m | -3.69m | 3.90m | 172.00 | -- | 0.7278 | -- | 0.2877 | -4.91 | -4.91 | 16.95 | 4.00 | 0.9917 | 3.11 | 5.04 | 78,761.63 | -26.98 | -29.36 | -35.49 | -40.65 | 38.52 | 38.00 | -27.21 | -30.93 | 2.84 | -- | 0.0151 | -- | -4.05 | -7.66 | 6.13 | -- | -29.84 | -- |
Data as of Nov 22 2024. Currency figures normalised to Universe Pharmaceuticals Inc's reporting currency: US Dollar USD
2.79%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| UBS Securities LLCas of 30 Sep 2024 | 242.46k | 1.03% |
| MML Investors Services LLCas of 30 Sep 2024 | 234.26k | 0.99% |
| Two Sigma Securities LLCas of 30 Sep 2024 | 90.37k | 0.38% |
| Renaissance Technologies LLCas of 30 Sep 2024 | 39.27k | 0.17% |
| Quadrature Capital Ltd.as of 30 Sep 2024 | 24.89k | 0.11% |
| XTX Markets LLCas of 30 Sep 2024 | 14.82k | 0.06% |
| Millennium Management LLCas of 30 Sep 2024 | 13.81k | 0.06% |
| Acadian Asset Management LLCas of 30 Sep 2024 | 0.00 | 0.00% |
More ▼
Data from 30 Sep 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
